Arterial ischemic stroke in children with congenital heart diseases

Hye-Ryun Yeh1, Eun-Hee Kim2, Jeong-Jin Yu3

  • 1Department of Pediatrics, Seoul Medical Center, Seoul, Korea.

Insights

Children with congenital heart disease (CHD) and arterial ischemic stroke (AIS) often have additional risk factors. Middle cerebral artery involvement and hemorrhagic transformation predict poor outcomes in pediatric AIS patients with CHD.

Area of Science:

  • Pediatric Neurology
  • Cardiology
  • Stroke Research

Background:

  • Congenital heart disease (CHD) is a significant risk factor for arterial ischemic stroke (AIS) in children.
  • Understanding the prevalence, risk factors, and outcomes of AIS in pediatric CHD patients is crucial for improving care.

Purpose of the Study:

  • To investigate the prevalence of thromboembolic risk factors and neurologic outcomes in children diagnosed with both congenital heart disease and arterial ischemic stroke.
  • To identify predictors of unfavorable outcomes in this vulnerable pediatric population.

Main Methods:

  • Retrospective analysis of clinical data from children with CHD and AIS between 2000 and 2016.
  • Evaluation of demographics, procedural data, neuroimaging, antithrombotic treatments, and neurological status at follow-up.

Main Results:

  • Cyanotic CHD was prevalent in 24 of 30 AIS cases; 70% of AIS events were procedure-related.
  • Additional thromboembolic causes were present in 46.7% of patients; 10% experienced recurrent AIS, and 20% developed post-stroke epilepsy.
  • Unfavorable outcomes (including death) occurred in 43.3%, significantly associated with middle cerebral artery main branch involvement and hemorrhagic transformation.

Conclusions:

  • Thromboembolic risk factors, including cardiac thrombus, arrhythmias, and surgical procedures, are common in pediatric AIS patients with CHD.
  • Main branch middle cerebral artery involvement and hemorrhagic transformation are key predictors of poor neurologic outcomes.
  • Further research is needed to develop targeted stroke prevention and prophylactic strategies for children with CHD.
Abstract